𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mechanism of action of a dominant negative c-jun mutant in inhibiting activator protein-1 activation

✍ Scribed by Eric J. Thompson; Ashok Gupta; M. Suzanne Stratton; G. Tim Bowden


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
144 KB
Volume
35
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The dominant negative c‐jun TAM‐67 has been shown to inhibit tumor promotion induced by 12‐O‐tetradecanoylphorbol‐13‐acetate and okadaic acid (OA). To better understand this phenomenon, we investigated the mechanism of action of TAM‐67 in response to OA. To identify the mechanism of action, we used a 6xHis‐tagged TAM‐67 as well as chimeric constructs of TAM‐67 that either cannot bind DNA or cannot heterodimerize with wild‐type transcription factors. The results of these studies indicated that TAM‐67 acts by blocking or squelching. The results of elecrophoretic mobility‐shift assays showed that TAM‐67 must act by squelching in response to OA, as TAM‐67 cannot be found in DNA‐binding complexes. We then identified some of the proteins with which TAM‐67 interacts. They include all members of the jun and fos families as well as the cAMP response element binding protein, activating transcription factor‐1, activating transcription factor‐2, and RelA (p65). Thus, we have shown that TAM‐67 squelches the induction of activating transcription factor‐1 transactivation in response to OA and that TAM‐67 is capable of interacting with proteins that control transactivation by binding to the 12‐O‐tetradecanoylphorbol‐13‐acetate response element, cAMP response element and nuclear factor‐κB sites. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Mutant human tumor suppressor p53 modula
✍ Anthony P. Gulati; Yang-Ming Yang; David Harter; Asok Mukhopadhyay; Bharat A. Ag 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

## Abstract The roles of the mitogen‐activated kinase protein (MAPK) pathway, nuclear factor‐kappa B (NF‐κB), and activator protein‐1 (AP‐1) in cellular responses to growth factors and mitogen are well established. However, the manner by which these proliferative pathways are affected by the tumor

2-deoxyglucose inhibits chemotheapeutic
✍ Naomi Haga; Mikihiko Naito; Hiroyuki Seimiya; Akihiro Tomida; Jian Dong; Takashi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 119 KB 👁 2 views

Human monocytic leukemia U937 cells undergo apoptosis when treated with antitumor drugs, such as etoposide, camptothecin and mitomycin C. The molecular mechanism of the drug-induced apoptosis is not well understood. In this study, we found that 2-deoxyglucose (2DG), an analog of D-glucose and an ind

A dominant negative mutant of jun blocki
✍ Zigang Dong; Howard C. Crawford; Vadim Lavrovsky; Dennis Taub; Rebecca Watts; Ly 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

We previously reported that induced activator protein-1 (AP-1) transcriptional activity appears to be required for tumor promoter-induced transformation in mouse epidermal JB6 cells. To extend this investigation to a keratinocyte culture model and a transgenic mouse model, we constructed K14TAM67, a

A peptide fragment of ependymin neurotro
✍ David S. Adams; Brendan Hasson; Anne Boyer-Boiteau; Adam El-Khishin; Victor E. S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 1 views

## Abstract Ependymin (EPN) is a goldfish brain neurotrophic factor previously shown to function in a variety of cellular events related to long‐term memory formation and neuronal regeneration. CMX‐8933, an 8‐amino‐acid synthetic peptide fragment of EPN, was designed for aiding an investigation of